**Teenager Shares Her Struggles with Epidermolysis Bullosa on National Television**
:max_bytes(150000):strip_icc():format(jpeg)/Jasmine-Ritchie-Butterfly-skin-tout-091426-55ed2103a7594b5d90a43ab95da5b558.jpg)
A 14-year-old girl from England, Jasmine Ritchie, has opened up about her daily battle with Epidermolysis Bullosa (EB), a rare skin disorder often referred to as “butterfly skin.” Jasmine appeared on the ITV programme *Good Morning Britain* on 11 September, where she candidly described the chronic pain and challenges she faces as a result of her condition.
Epidermolysis Bullosa is a genetic disorder that makes the skin extremely fragile, leading to blistering from minor injuries, heat, or even simple friction. The condition is likened to the delicate wings of a butterfly, hence the nickname “butterfly disease.” According to information from the Mayo Clinic, individuals with EB can experience scarring, infection, and significant discomfort on a daily basis.
Jasmine spoke movingly about her experiences, stating, “We just have to live with pain throughout the day, every day. We just have to get used to it; we have no other choice.” Her reality includes wearing daily bandages, a painstaking process that takes her three to four hours each day.
Although she enjoys going to school, Jasmine shared that even the simplest tasks can be a struggle. “It’s just a lot harder than for most kids. Even just getting my pencil case out of my bag, I just need help for those things,” she explained, highlighting the constant challenges of her condition.
Also featured on the programme was former Liverpool footballer Graeme Souness, who is now the president of DEBRA, a charity that provides support for those affected by EB in the UK. Souness expressed his deep concern regarding the condition, remarking, “It’s a condition that was sent by the devil.”
Souness, 73, is gearing up for an ambitious challenge aimed at raising funds for EB research and support. From 15 to 17 September, he plans to climb the highest peaks in England, Scotland, and Wales—Ben Nevis, Scafell Pike, and Snowdon—and will also undertake open-water swims near each location. The endeavour aims to generate awareness and financial support for those suffering from EB.
In a statement before his planned challenge, Souness said, “I’m taking on my toughest challenge yet for everyone living with the agony of EB. Three peaks. Three open-water swims. Three days. It will be brutal — but nothing compared to the pain children and adults with EB face every day.” He emphasised the urgency of fundraising, noting that at least £500,000 is needed to support a new clinical trial for effective treatments.
Jasmine’s appearance on *Good Morning Britain* adds to her previous efforts to raise awareness about living with Epidermolysis Bullosa. In a prior interview, she expressed her desire for others to grasp the severity and pain associated with the condition. “I want people to understand just how painful it really is,” she said.
The American Academy of Dermatology notes that EB is relatively rare, afflicting an estimated 25,000 to 50,000 individuals in the United States. This rarity, however, is no less significant for those living with the condition, as highlighted by both Jasmine and Souness.
As awareness grows, Jasmine’s story serves as a poignant reminder of the realities faced by those with Epidermolysis Bullosa. Her resilience and determination to cope with an often debilitating condition shine a light on the need for continued research and support for affected individuals and their families. The challenge undertaken by Graeme Souness also underscores the collective efforts required to progress toward effective treatments for EB, echoing the sentiments shared by Jasmine and many others in the fight against this difficult disorder.
The widespread impact of such initiatives, combined with personal testimonies like Jasmine’s, plays a vital role in fostering understanding and support for individuals battling Epidermolysis Bullosa every day. Through their efforts, there is hope for a future with better treatment options and improved quality of life for those affected by this challenging condition.